Alternative medications for epilepsy of infancy with migrating focal seizures; Potassium bromide and ketogenic diet

2017 ◽  
Vol 21 ◽  
pp. e36-e37
Author(s):  
İpek Polat ◽  
Muge Ayanoglu ◽  
Derya Okur ◽  
Pinar Edem ◽  
Cem Paketci ◽  
...  
2018 ◽  
Vol 40 (8) ◽  
pp. 724-727 ◽  
Author(s):  
Da-Jyun Su ◽  
Jyh-Feng Lu ◽  
Li-Ju Lin ◽  
Jao-Shwann Liang ◽  
Kun-Long Hung

2001 ◽  
Vol 15 (11) ◽  
pp. 85
Author(s):  
J Gordon Millichap

2019 ◽  
Vol 34 (12) ◽  
pp. 728-734 ◽  
Author(s):  
Anita N. Datta ◽  
Aspasia Michoulas ◽  
Ilaria Guella ◽  
Michelle Demos ◽  

KCNT1 encodes a sodium-activated potassium channel highly expressed in the brain, regulating hyperpolarization following repetitive firing. Mutations in KCNT1 were originally implicated in autosomal-dominant nocturnal frontal lobe epilepsy and epilepsy of infancy with migrating focal seizures. It is now known that there is variability in phenotypic expression and incomplete penetrance. We describe 2 patients with KCNT1-related epilepsy, one with epilepsy of infancy with migrating focal seizures and one with multifocal epilepsy. As most patients with KCNT1 variants have treatment-resistant epilepsy, drugs that specifically target the KCNT1 channel have been of great interest. Quinidine, a broad-spectrum potassium channel blocker, has shown promise; however, clinical trial results have been variable. Our patient with epilepsy of infancy with migrating focal seizures did not respond to a trial of quinidine at 6 weeks of age—one of the earliest reported quinidine trials in the literature for KCNT1-related epilepsy. This indicates that timing of treatment and response may not be related. Both patients responded to high-dose phenobarbital. The patient with epilepsy of infancy with migrating focal seizures also had a significant reduction in seizures with potassium bromide (KBr). Our data suggest that alternative therapies to quinidine should be considered as a therapeutic option for patients with KCNT1-related epilepsy. Although improved seizure control led to parent-reported improvements in neurodevelopment, it is unknown if phenobarbital and KBr impact the overall developmental trajectory of patients with KCNT1-related epilepsy. Further multicenter longitudinal studies are required.


2021 ◽  
Vol 18 (2) ◽  
pp. 137-141
Author(s):  
Hyejin Na ◽  
Sanghoon Lee ◽  
Young Ok Kim

2015 ◽  
Vol 17 (2) ◽  
pp. 194-197 ◽  
Author(s):  
Roberto Caraballo ◽  
Daniel Noli ◽  
Pedro Cachia

2019 ◽  
Vol 95 ◽  
pp. 92 ◽  
Author(s):  
Priyanka Madaan ◽  
Prashant Jauhari ◽  
Biswaroop Chakrabarty ◽  
Sheffali Gulati

2020 ◽  
Vol 51 (06) ◽  
pp. 417-420
Author(s):  
Atsuro Daida ◽  
Shin-ichiro Hamano ◽  
Satoru Ikemoto ◽  
Yuko Hirata ◽  
Ryuki Matsuura ◽  
...  

Abstract Background Nonketotic hyperglycinemia is a severe form of early onset epileptic encephalopathy caused by disturbances in the glycine cleavage system; the neurological damage is mainly attributed to overstimulation of the N-methyl-D-aspartate receptor. Case The patient presented with a severe form of nonketotic hyperglycinemia and experienced frequent epileptic spasms and focal seizures, which were resistant to vigabatrin, adrenocorticotropic hormone therapy, and combined dextromethorphan and sodium benzoate treatments. By 9 months of age, perampanel reduced epileptic spasms by >50%. At 14 months of age, the ketogenic diet markedly reduced focal seizures and glycine levels in the cerebrospinal fluid. Conclusion Perampanel reduced fast excitatory neuronal activity, which was induced by an α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor, followed by prolonged electrical depolarizations due to an N-methyl-D-aspartate receptor. Furthermore, the ketogenic diet may have modulated the excessive neurotoxic cascade through the N-methyl-D-aspartate receptor. Perampanel and ketogenic diet were effective for seizure control in our patient.


Sign in / Sign up

Export Citation Format

Share Document